27.02.2012 13:06 Uhr, Quelle: Wallstreet online

European Commission Approves Esmya® for the Pre-Operative Treatment of Uterine Fibroids (myomas)

BUDAPEST, Hungary, February 27, 2012 /PRNewswire/ Gedeon Richter Plc. ("Richter") announced today that the European Commission (EC) has granted marketing authorization to Esmya(R)5mg tablet aspre-operative treatment of moderate to severe …

Weiterlesen bei Wallstreet online